EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
We provide a simplified algorithm of prevention, diagnosis and treatment of severe allergic reactions and a list of recommended medications and equipment for vaccine centres.
We also describe potentially allergenic/immunogenic components of the approved vaccines and propose a workup to identify the responsible allergen. Finally, we identify unmet research needs and propose a concerted international roadmap towards precision diagnosis and management to minimise the risk of allergic reactions to COVID‐19 vaccines and to facilitate their broader and safer use.